Researchers found that the field of longevity medicine often overlooks the unique health needs of women, treating male biology as the default and female biology as an exception. This bias can lead to poorer health outcomes for women, who, despite living longer than men, often spend more years in poor health. Dr. Poonam Desai, a leading voice in preventive health, emphasizes the need for sex-specific medicine that accurately reflects women’s health issues, including menopause and hormonal changes, which significantly impact aging and longevity.

This discussion is particularly relevant for anyone interested in aging well. Women, in particular, may benefit from a healthcare approach that acknowledges their unique physiological needs. For example, conditions like cardiovascular disease can present differently in women, and many women experience delays in diagnosis for various health issues. By addressing these gaps, women could potentially improve their healthspan—the period of life spent in good health—thereby enhancing their quality of life as they age.

The evidence presented by Dr. Desai highlights a critical issue in current medical research, which has historically excluded women from clinical trials. This has resulted in a healthcare system that often fails to provide appropriate care for women. While the conversation around personalized medicine is evolving, it remains essential to ensure that future research includes sex-disaggregated data and that medical protocols are recalibrated to reflect women’s health needs.

To support this shift, individuals can advocate for more inclusive healthcare practices and seek providers who prioritize sex-specific medicine. It’s crucial to understand that personalized health should not merely adapt male protocols for women but create entirely new frameworks that consider women’s unique biological and health experiences.

Source: longevity.technology